Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

Detalles Bibliográficos
Autores principales: Legault, Kimberly, Blostein, Mark, Carrier, Marc, Kahn, Susan, Schulman, Sam, Shivakumar, Sudeep, Wu, Cynthia, Crowther, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236369/
https://www.ncbi.nlm.nih.gov/pubmed/32477586
http://dx.doi.org/10.1186/s40814-020-00614-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236369/
https://www.ncbi.nlm.nih.gov/pubmed/32477586
http://dx.doi.org/10.1186/s40814-020-00614-0

Ejemplares similares